Cannon-Global-Investment-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-28
Total Holdings
76
Total Value
50302095
Accession Number
0001844427-25-000004
Form Type
13F-HR
Manager Name
Cannon-Global-Investment-Management
Data Enrichment
95% identified
72 identified4 unidentified

Holdings

76 positions
Manager:
Search and click to pin securities to the top
Page 4 of 4
Lifevantage Corp
Shares:10.7K
Value:$156.0K
Eton Pharmaceuticals, Inc.
Shares:11.4K
Value:$148.0K
Emergent BioSolutions Inc.
Shares:29.6K
Value:$143.9K
aTYR PHARMA INC
Shares:47.5K
Value:$143.4K
ClearPoint Neuro, Inc.
Shares:12.0K
Value:$142.7K
eHealth, Inc.
Shares:18.1K
Value:$120.9K
Corvus Pharmaceuticals, Inc.
Shares:35.0K
Value:$111.3K
Ferroglobe PLC
Shares:26.0K
Value:$96.5K
INDIVIOR PLC
Shares:10.0K
Value:$95.3K
Amylyx Pharmaceuticals, Inc.
Shares:25.5K
Value:$90.3K
MIMEDX GROUP, INC.
Shares:10.0K
Value:$76.0K
ABEONA THERAPEUTICS INC.
Shares:14.0K
Value:$66.6K
Gevo, Inc.
Shares:50.0K
Value:$58.0K
Aclaris Therapeutics, Inc.
Shares:37.4K
Value:$57.2K
Eos Energy Enterprises, Inc.
Shares:15.0K
Value:$56.7K
Checkpoint Therapeutics, Inc.
Shares:10.0K
Value:$40.4K